Jagsonpal Pharmaceuticals has informed that the Trading Window for dealing in securities of Jagsonpal Pharmaceuticals (the Company) shall remain closed for Designated Persons and their Immediate relative(s) with effect from Sunday, October 01, 2023 till the end of 48 hours after the declaration of Unaudited Financial Result for quarter and half year ended September 30, 2023.
The above information is a part of company’s filings submitted to BSE.